Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Singh, B. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Singh, B. N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Recent advances in the management of atrial fibrillation

Bramah N. Singh*

David Geffen School of Medicine at UCLA, and VA Greater Los Angeles Health Care System, 11301 Wilshire Boulevard, Los Angeles, CA 90073, USA

* Corresponding author. Tel: +1 310 268 3436; fax: +1 310 473 0724. E-mail address: bramah.singh@va.gov or bsingh@ucla.edu

The first 10% of the full text of this article appears below.

Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice, with over 3 million cases in the USA and 4.5 million in Europe. Its incidence is rising rapidly, and the number of individuals with AF is expected to triple or even quadruple between now and 2050. Most patients with AF are over 65 years of age and present many co-morbidities, in particular, hypertension (37%), heart failure (23%), coronary artery disease (18%), and diabetes (15%). The majority of patients with AF are elderly and 83% are aged over 65 years. This subset of patients is likely to continue to increase in number. AF is a major source of morbidity and mortality, being associated with reduced left ventricular function, exercise tolerance and quality of life, as well . . . [Full Text of this Article]


   The CREATE Scientific Committee 2007
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?